Applied DNA Sciences Announces Industry Contracts for SigNature(R) DNA Marking of Electronics
November 29 2012 - 7:30AM
Marketwired
Applied DNA Sciences, Inc. (OTCBB: APDN), (Twitter: @APDN), a
provider of DNA-based anti-counterfeiting technology and product
authentication solutions, announced today that it has signed
multiple contracts in support of the mandate by the Defense
Logistics Agency for use of APDN's SigNature® DNA marking and
authentication technology.
These electronics companies have or will receive SigNature DNA
and essential materials and services from APDN for DNA marking
during or after manufacture. These steps will qualify them as
SigNature DNA-compliant.
For manufacturers, a SigNature DNA Authenticity Mark as applied
in production, certifies authenticity in an absolute, transparent
and verifiable manner. For distributors and others, a SigNature DNA
Provenance Mark establishes traceability to the point of the mark,
assuring the entire supply chain that the part can be tracked to a
supplier.
The contracts will enable electronics companies to fulfill the
DLA mandate, announced on August 7 in a clause in Defense Logistics
Acquisition Directive (DLAD) 52.211-9074, and expanded on November
7 with a provision at DLAD 52.211-9008. This mandate specifically
requires SigNature DNA marking for procurements of items falling
within Federal Supply Class 5962, Electronic Microcircuits. The
requirement applies only to procurements made by DLA.
The developing list of participating defense contractors will
enable the military electronics supply chain to move toward
compliance with the anti-counterfeiting language in Section 818 of
the National Defense Authorization Act for Fiscal Year 2012
(Section 818). A major deadline for Section 818, which imposes
strict requirements for control of counterfeits, is due to be
reached very soon. In a press announcement released on October 31,
DLA pointed to the connection between the mandate and the coming
implementation of NDAA Section 818:
The new requirement also facilitates the goals of Congress to
protect DoD's supply chains and national cybersecurity, which
Congress outlined in the 2012 National Defense Authorization Act.
This requires DoD, as well as industry, to develop counterfeit item
detection and prevention measures for electronic items.
In the same press announcement, DLA stressed the "broad
implications" of its DNA marking mandate, stretching beyond
electronics, saying:
DLA is initially targeting microelectronics, but the technology
is used with other commodities commercially and has broad
implications for other DLA products and equipment at risk for
counterfeiting.
APDN suggested that electronics companies check with suppliers
to find whether they have joined the list of companies which are
SigNature DNA-compliant.
Janice Meraglia, Vice President, Military and Government
Programs for Applied DNA Sciences, said, "DLA, in its efforts to
provide support to our war fighters, has worked for years to
develop new technology and processes to mitigate counterfeit risk.
We are pleased to see these efforts materialized in the electronics
industry, something which will benefit industry and national
security."
About Applied DNA Sciences
APDN is a provider of botanical-DNA based security and
authentication solutions that can help protect products, brands and
intellectual property of companies, governments and consumers from
theft, counterfeiting, fraud and diversion. SigNature® DNA and
smartDNA, our principal anti-counterfeiting and product
authentication solutions that essentially cannot be copied, provide
a forensic chain of evidence and can be used to prosecute
perpetrators.
The statements made by APDN may be forward-looking in nature.
Forward-looking statements describe APDN's future plans,
projections, strategies and expectations, and are based on
assumptions and involve a number of risks and uncertainties, many
of which are beyond the control of APDN. Actual results could
differ materially from those projected due to our short operating
history, limited financial resources, limited market acceptance,
market competition and various other factors detailed from time to
time in APDN's SEC reports and filings, including our Annual Report
on Form 10-K, filed on December 8, 2011 and our subsequent
quarterly reports on Form 10-Q. APDN undertakes no obligation to
update publicly any forward-looking statements to reflect new
information, events or circumstances after the date hereof to
reflect the occurrence of unanticipated events.
MEDIA CONTACT: Mitchell Miller 646-543-3373 fax: 631-444-8848
INVESTOR CONTACT: Debbie Bailey 631-444-8090 fax: 631-444-8848 FCMN
Contact: Email Contact PROGRAM CONTACT: Janice Meraglia
631-444-6293 Web site: http://www.adnas.com Twitter: @APDN,
@APDNInvestor
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From Apr 2024 to May 2024
Applied DNA Sciences (NASDAQ:APDN)
Historical Stock Chart
From May 2023 to May 2024